Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTED.L Regulatory News (TED)

  • There is currently no data for TED

Changes to Board and Committee Composition

28 Jul 2022 14:36

RNS Number : 1392U
Ted Baker PLC
28 July 2022
 

 

 

Ted Baker Plc

(the "Company")

 

Changes to Board and Committee Composition

 

Ted Baker Plc today confirms the departure of Andrew Jennings as director of the Company. This announcement is made in compliance with section 430(2B) of the Companies Act 2006.

 

As previously announced on 17 December 2021, Andrew Jennings did not seek re-election to the Board at the Annual General Meeting on 28 July 2022. Andrew Jennings' directorship of the Company ceased on 28 July 2022. 

 

Andrew Jennings received his fees as a director to the date of termination and no other payments will be made.

 

Save as set out above, Andrew Jennings will not receive any other compensation or payment for ceasing to be a director. 

 

These terms are in line with the Company's shareholder-approved remuneration policy.

 

Helena Feltham, Interim Chair, said:

"On behalf of the Board, I would like to thank Andrew for his strong leadership, passion, and commitment during his 8 years at Ted. In addition to his role as Remuneration Committee Chair, we have hugely valued his global retail and merchant experience and the continuity he has provided to the board following the death of John Barton." 

 

Andrew Jennings said:

"I am thrilled to have been part of this unique British heritage brand over the latter 8 years. I wish Helena Feltham, the Board and the Management team much success in implementing the critically important turnaround strategy over the next 18 months in line with the changing customer needs".

 

Ted Baker also announces the following committee changes have been agreed:

Nominations Committee

Remuneration Committee

Audit & Risk Committee

Fumbi Chima

-

-

Member

Jon Kempster

-

Chair

-

Meg Lustman

Member

Member

-

 

As a result of these changes, the composition of the Board committees is:

Nominations Committee

Remuneration Committee

Audit & Risk Committee

Helena Feltham

Chair

Member

Member

Fumbi Chima

-

-

Member

Jon Kempster

Member

Chair

Chair

Meg Lustman

Member

Member

-

 

As previously noted, Helena Feltham assumed the role of Interim Chair on 6 December 2021. This temporary role is in addition to her existing responsibilities as Senior Independent Director, Chair of the Nominations Committee, member of the Audit Committee and member of the Remuneration Committee.

 

While we had made good progress on the search for a new Chair, on 18 March 2022, Sycamore Partners Management LP announced that it was considering a possible offer for the Company and we consequently announced on 4 April 2022 that we had commenced a formal sale process. The Board considered that continuity and experience was key to the Company successfully negotiating this period, and we accordingly paused the search for a new Chair pending the outcome of the formal sale process.

 

The Board notes the recommendations of the Financial Reporting Council's UK Corporate Governance Code as regards the role of the Chair of the Board. In particular, the Board is mindful of the recommendations that the Chair should not chair the Nominations Committee when it is dealing with the appointment of their successor, and that the Chair of the Board should not be a member of the Audit Committee. Notwithstanding the Code provisions, the Board does not propose to make any further changes to Helena's roles and responsibilities during the temporary period while she is acting as Interim Chair.

 

The Board believes that, as Chair of the Nominations Committee, Helena has the necessary experience to be responsible for appointment of a new Chair of the Board. As Helena does not wish to be considered as a candidate for the permanent position of Chair and is committed to a smooth and quick transition to a new Chair at the appropriate time, the Board does not consider there to be a conflict of interest. Should any conflict of interest arise, Helena will recuse herself from the relevant discussions. Additionally, the Board believes that any other short-term changes to Board committees to align the composition with the recommendations of the UK Corporate Governance Code would be disruptive and would not be in the best interests of the Company at a time when ensuring continuity is paramount.

 

 

 

 

 

For further information contact:

Tulchan Communications

Tel: +44 (0) 20 7353 4200

Jonathan Sibun / Jessica Reid

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAXVLFLLDLXBBZ
Date   Source Headline
10th Apr 20197:00 amRNSJoint Venture
4th Apr 20199:21 amRNSTotal Voting Rights
22nd Mar 20194:00 pmRNSFinal Dividend Payment Date
21st Mar 20197:00 amRNSFinal Results
4th Mar 20197:00 amRNSResignation of Chief Executive Officer
27th Feb 20197:00 amRNSUpdate on profit expectation for Year 18/19
18th Feb 20198:00 amRNSCommittee Changes
1st Feb 201910:04 amRNSTotal Voting Rights
22nd Jan 20197:00 amRNSAppointment of Joint Corporate Broker
9th Jan 20197:00 amRNSTrading Update
4th Jan 20198:40 amRNSNotice of Trading Update
11th Dec 201810:34 amRNSDirector/PDMR Shareholding
7th Dec 20184:27 pmRNSChief Executive Officer - Leave of Absence
6th Dec 20187:00 amRNSTrading Update
3rd Dec 201811:48 amRNSResponse to media reports and petition
16th Nov 201812:16 pmRNSNotice of Trading Update
5th Nov 20188:24 amRNSTotal Voting Rights
29th Oct 201812:23 pmRNSBlock Listing Return
4th Oct 20187:00 amRNSInterim Results
1st Oct 20182:56 pmRNSTotal Voting Rights
25th Sep 20187:00 amRNSNotice of Interim Results
10th Sep 20189:30 amRNSAcquisition
22nd Aug 20185:47 pmRNSHolding(s) in Company
22nd Aug 201812:53 pmRNSHolding(s) in Company
2nd Aug 20187:00 amRNSTotal Voting Rights
19th Jul 201811:56 amRNSHolding(s) in Company
13th Jul 201810:02 amRNSHolding(s) in Company
3rd Jul 20182:35 pmRNSDirector/PDMR Shareholding
2nd Jul 20183:23 pmRNSTotal Voting Rights
2nd Jul 20182:48 pmRNSHolding(s) in Company
22nd Jun 20183:45 pmRNSHolding(s) in Company
18th Jun 20183:27 pmRNSHolding(s) in Company
18th Jun 20189:39 amRNSHolding(s) in Company
18th Jun 20189:33 amRNSDirectorate Changes
12th Jun 20184:28 pmRNSResult of AGM
12th Jun 20187:00 amRNSTrading Update
4th Jun 20183:15 pmRNSTotal Voting Rights
31st May 201810:52 amRNSNotice of Trading Update
23rd May 20183:58 pmRNSNotice of AGM
18th May 20185:41 pmRNSHolding(s) in Company
15th May 201810:26 amRNSDirector/PDMR Shareholding
30th Apr 201811:22 amRNSBlock listing Return
5th Apr 20187:00 amRNSDirector/PDMR Shareholding
3rd Apr 20181:38 pmRNSTotal Voting Rights
29th Mar 20187:00 amRNSDirector/PDMR Shareholding
28th Mar 20181:42 pmRNSDirector/PDMR Shareholding
22nd Mar 20187:00 amRNSFinal Results
20th Feb 20187:00 amRNSDirectorate Changes
2nd Feb 201811:15 amRNSTotal Voting Rights
15th Jan 20182:34 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.